AbCellera Biologics Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABCL Nasdaq 2834 www.abcellera.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbCellera Biologics Inc.

After Golden Cross, AbCellera Biologics Inc. (ABCL)'s Technical Outlook is Bright - May 29th, 2026 7:55 am
Does AbCellera (ABCL) Have a Clear Path From ABCL635 Data to a Durable Business Model? - May 24th, 2026 8:13 am
Here’s Why AbCellera (ABCL) is Among the 10 Best Penny Stocks to Buy for Long Term - May 22nd, 2026 12:43 pm
Wall Street Analysts Believe ABCELLERA BIOLG (ABCL) Could Rally 97.28%: Here's is How to Trade - May 22nd, 2026 7:55 am
7 Healthcare AI Stocks Under $50 With Huge Upside Potential - May 18th, 2026 5:35 am
Are Medical Stocks Lagging ABCELLERA BIOLG (ABCL) This Year? - May 14th, 2026 7:40 am
Earnings Update: Here's Why Analysts Just Lifted Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$10.14 - May 14th, 2026 6:58 am
AbCellera Moves ABCL635 Into Phase 2 As Losses Continue - May 12th, 2026 6:27 pm
AbCellera Biologics Inc (ABCL) Q1 2026 Earnings Call Highlights: Promising Advancements Amid ... - May 12th, 2026 1:07 am
AbCellera Biologics Q1 Earnings Call Highlights - May 11th, 2026 5:05 pm
AbCellera (ABCL) Q1 2026 Earnings Transcript - May 11th, 2026 4:30 pm
AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Beats Revenue Estimates - May 11th, 2026 3:25 pm
AbCellera Reports Q1 2026 Business Results & Announces Positive Interim Phase 1 Clinical Data for ABCL635 - May 11th, 2026 2:05 pm
Absci Corporation (ABSI) Reports Q1 Loss, Misses Revenue Estimates - May 7th, 2026 8:25 pm
Why AbCellera Biologics (ABCL) Is Up 16.1% After ABCL635 Trial Momentum Builds Ahead Of Data - May 7th, 2026 5:16 pm
AbCellera to Present at Upcoming Investor Conferences in May and June 2026 - May 7th, 2026 2:05 pm
JonesResearch Reiterates Buy on AbCellera Biologics (ABCL) - May 5th, 2026 5:39 am
A Look At AbCellera Biologics (ABCL) Valuation As It Prepares ABCL635 Phase 1 Interim Update - May 2nd, 2026 11:13 am
AbCellera Biologics Among 3 Promising Penny Stocks - May 1st, 2026 6:05 am
AbCellera Biologics Pivots to In-House Pipeline, Teases Q3 Phase II Data for ABCL635 Hot Flashes - Apr 24th, 2026 6:43 am